Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1997 | 06-1997 | 03-1997 | 12-1996 | 09-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,673 | 130,253 | 148,302 | 148,230 | 112,111 |
| Marketable Securities | 82,013 | 78,148 | 98,079 | 62,810 | 71,308 |
| Receivables | 64,809 | 46,527 | 35,713 | 27,150 | 25,721 |
| Inventories | 44,699 | 44,488 | 32,652 | 23,210 | 26,303 |
| Other current assets | 10,170 | 20,613 | 29,522 | 18,190 | 21,166 |
| TOTAL | $302,364 | $320,029 | $344,268 | $279,590 | $256,609 |
| Non-Current Assets | |||||
| PPE Net | 127,039 | 122,904 | 116,739 | 111,320 | 110,063 |
| Investments And Advances | 160,447 | 135,454 | 79,288 | 61,160 | 60,148 |
| Other Non-Current Assets | 197,369 | 198,850 | 6,854 | 5,240 | 5,427 |
| TOTAL | $484,855 | $457,208 | $202,881 | $177,720 | $175,638 |
| Total Assets | $742,001 | $733,592 | $505,645 | $419,590 | $395,194 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 812 | 817 | 673 | 670 | 621 |
| Accounts payable and accrued liabilities | 39,770 | 34,302 | 33,650 | 20,200 | 24,320 |
| Other current liabilities | 45,000 | 100,000 | 0 | 0 | 0 |
| TOTAL | $92,253 | $141,225 | $36,281 | $21,350 | $34,925 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,648 | 2,848 | 2,741 | 2,900 | 3,116 |
| Other Non-Current Liabilities | 50,767 | 50,586 | 459 | 400 | 0 |
| TOTAL | $97,145 | $89,474 | $24,740 | $15,520 | $3,116 |
| Total Liabilities | $189,398 | $230,699 | $61,021 | $36,880 | $38,041 |
| Shareholders' Equity | |||||
| Common Shares | 290 | 144 | 134 | 120 | 121 |
| Retained earnings | 245,613 | 218,015 | 216,445 | 216,000 | 196,328 |
| Other shareholders' equity | 51,249 | 39,021 | 17,400 | 7,200 | 5,673 |
| TOTAL | $552,603 | $502,893 | $444,624 | $382,710 | $357,153 |
| Total Liabilities And Equity | $742,001 | $733,592 | $505,645 | $419,590 | $395,194 |